Comparison of pharmacokinetics of a lm coated tablet formulation and an orally disintegrating tablet (ODT) formulation of etoricoxib in healthy subjects and evaluation opf the taste properties and taste masking efforts for the etoricoxib ODT formulation

Trial Profile

Comparison of pharmacokinetics of a lm coated tablet formulation and an orally disintegrating tablet (ODT) formulation of etoricoxib in healthy subjects and evaluation opf the taste properties and taste masking efforts for the etoricoxib ODT formulation

Completed
Phase of Trial: Phase I

Latest Information Update: 02 Apr 2018

At a glance

  • Drugs Etoricoxib (Primary)
  • Indications Osteoarthritis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 02 Apr 2018 New trial record
    • 24 Mar 2018 Results presented at the 119th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top